Wang W, Truong K, Ye C, Sharma S, He H, Liu L
Front Immunol. 2023; 14:1167965.
PMID: 37781368
PMC: 10538569.
DOI: 10.3389/fimmu.2023.1167965.
Valdebenito S, Ono A, Rong L, Eugenin E
NeuroImmune Pharm Ther. 2023; 2(2):169-186.
PMID: 37476291
PMC: 10355284.
DOI: 10.1515/nipt-2022-0015.
Baratella M, Iannone V, Cavarelli M, Foglieni C, Vigano P, Moog C
Front Immunol. 2023; 14:1133886.
PMID: 37033941
PMC: 10073423.
DOI: 10.3389/fimmu.2023.1133886.
Caputo V, Libera M, Sisti S, Giuliani B, Diotti R, Criscuolo E
Front Immunol. 2023; 14:1104423.
PMID: 36798134
PMC: 9927018.
DOI: 10.3389/fimmu.2023.1104423.
Wang T, Gu Y, Ran L, Tan X, Peng S
Front Public Health. 2022; 10:941941.
PMID: 36159288
PMC: 9493025.
DOI: 10.3389/fpubh.2022.941941.
Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression.
Delgado-Diaz D, Jesaveluk B, Hayward J, Tyssen D, Alisoltani A, Potgieter M
Microbiome. 2022; 10(1):141.
PMID: 36045402
PMC: 9429363.
DOI: 10.1186/s40168-022-01337-5.
Antibody-mediated prevention of vaginal HIV transmission is dictated by IgG subclass in humanized mice.
Brady J, Phelps M, MacDonald S, Lam E, Nitido A, Parsons D
Sci Transl Med. 2022; 14(655):eabn9662.
PMID: 35895834
PMC: 9507259.
DOI: 10.1126/scitranslmed.abn9662.
The Effect of Contraception on Genital Cytokines in Women Randomized to Copper Intrauterine Device, Depot Medroxyprogesterone Acetate, or Levonorgestrel Implant.
Tanko R, Bunjun R, Dabee S, Jaumdally S, Onono M, Nair G
J Infect Dis. 2022; 226(5):907-919.
PMID: 35263421
PMC: 9470113.
DOI: 10.1093/infdis/jiac084.
Detecting Selection in the HIV-1 Genome during Sexual Transmission Events.
Seifert D, Joos B, Braun D, Oberle C, Schenkel C, Kuster H
Viruses. 2022; 14(2).
PMID: 35215999
PMC: 8876189.
DOI: 10.3390/v14020406.
Epidemiological Characteristics and Transmissibility of Human Immunodeficiency Virus in Nanning City, China, 2001-2020.
Lin Q, Deng B, Rui J, Guo S, Hu Q, Chen Q
Front Public Health. 2022; 9:689575.
PMID: 35004557
PMC: 8733253.
DOI: 10.3389/fpubh.2021.689575.
The Microbiome as a Key Regulator of Female Genital Tract Barrier Function.
Plesniarski A, Siddik A, Su R
Front Cell Infect Microbiol. 2022; 11:790627.
PMID: 34976864
PMC: 8719631.
DOI: 10.3389/fcimb.2021.790627.
Inhibition of miR-155 Promotes TGF-β Mediated Suppression of HIV Release in the Cervical Epithelial Cells.
Gokavi J, Sadawarte S, Shelke A, Kulkarni-Kale U, Thakar M, Saxena V
Viruses. 2021; 13(11).
PMID: 34835072
PMC: 8624372.
DOI: 10.3390/v13112266.
Preventive HIV Vaccines-Leveraging on Lessons from the Past to Pave the Way Forward.
Sobia P, Archary D
Vaccines (Basel). 2021; 9(9).
PMID: 34579238
PMC: 8472969.
DOI: 10.3390/vaccines9091001.
Anatomic Distribution of Intravenously Injected IgG Takes Approximately 1 Week to Achieve Stratum Corneum Saturation in Vaginal Tissues.
Carias A, Schneider J, Madden P, Lorenzo-Redondo R, Arainga M, Pegu A
J Immunol. 2021; 207(2):505-511.
PMID: 34162723
PMC: 8516693.
DOI: 10.4049/jimmunol.2100253.
Functionalized gold nanoparticles: promising and efficient diagnostic and therapeutic tools for HIV/AIDS.
Gulati S, Singh P, Diwan A, Mongia A, Kumar S
RSC Med Chem. 2021; 11(11):1252-1266.
PMID: 34095839
PMC: 8126886.
DOI: 10.1039/d0md00298d.
Exosomes Transport Anti-Human Immunodeficiency Virus Factors from Human Cervical Epithelial Cells to Macrophages.
Xu X, Zhang B, Guo L, Liu Y, Meng F, Wang X
J Innate Immun. 2021; 13(5):269-279.
PMID: 34082434
PMC: 8460989.
DOI: 10.1159/000514886.
Semen: A modulator of female genital tract inflammation and a vector for HIV-1 transmission.
Jewanraj J, Ngcapu S, Liebenberg L
Am J Reprod Immunol. 2021; 86(5):e13478.
PMID: 34077596
PMC: 9286343.
DOI: 10.1111/aji.13478.
HIV and Sexual Dysfunction in Men.
De Vincentis S, Tartaro G, Rochira V, Santi D
J Clin Med. 2021; 10(5).
PMID: 33807833
PMC: 7961513.
DOI: 10.3390/jcm10051088.
Nanosystems Applied to HIV Infection: Prevention and Treatments.
Macchione M, Bedoya D, Figueroa F, Munoz-Fernandez M, Strumia M
Int J Mol Sci. 2020; 21(22).
PMID: 33212766
PMC: 7697905.
DOI: 10.3390/ijms21228647.
Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection.
Macharia G, Yue L, Staller E, Dilernia D, Wilkins D, Song H
PLoS Pathog. 2020; 16(9):e1008853.
PMID: 32886726
PMC: 7498102.
DOI: 10.1371/journal.ppat.1008853.